top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
An Alaska campaign for the Alaska Natural Medicine Act, which seeks to legalize certain psychedelics like psilocybin and DMT, failed to collect the required signatures to qualify for the 2026 ballot, but they are shifting their focus to the 2028 election cycle. The campaign collected over 10,000 signatures, which will carry over toward the roughly 35,000 needed, emphasizing that the proposal—which includes establishing a licensed industry and non-commercial use—has growing support in the state.

Alaska Psychedelics Advocates Drop 2026 Ballot Effort and Set Sights on 2028

Dec 12, 2025

Source:

Kyle Jaeger

Marijuana Moment

The effort to legalize psychedelics in Alaska is taking a breather, but the fire is definitely still burning. Natural Medicine Alaska recently announced they couldn't gather the 35,000 signatures required to make the 2026 ballot. While they fell short with about 10,000 names, those signatures aren't going to waste—they’ll carry over as the campaign pivots to a 2028 goal. The proposed Alaska Natural Medicine Act aims to create a regulated market for substances like psilocybin and DMT, while also protecting traditional healing and "grow, gather, gift" models.

This delay is a bit of a bummer for those of us who view plant medicine as a vital companion to cannabis, but it's a strategic win that the momentum isn't starting from scratch. For the average toker, this matters because it represents the broader fight for cognitive liberty and natural wellness. Seeing Alaska follow the lead of Colorado and Oregon shows that the movement for accessible, alternative medicine is becoming a permanent fixture in state politics, even if the road is a little long.

Recent Reviews

bottom of page